Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Jacobson PharmaHKSE:02633 -0.96%56 Dividend Yield % is 9.33% as of Sep. 02, 2026, which is 75% above its 10-year median of 5.33. GuruFocus rates HKSE:02633 with a GF Score™ of 56/100 and a GF Value™ of HK$0.85 (Modestly Overvalued). The stock has 2 warning signs investors should review. Among 508 Drug Manufacturers companies, Jacobson Pharma ranks better than 98.23% on this metric.
As of today (2026-09-02), the Trailing Annual Dividend Yield of Jacobson Pharma is 9.33%.
Good Sign:
Jacobson Pharma Corp Ltd stock Dividend Yield % is close to 10-year high.
The historical rank and industry rank for Jacobson Pharma's Dividend Yield % or its related term are showing as below:
HKSE:02633'
s Dividend Yield % Range Over the Past 10 Years
Min: 0.6 Med: 5.33 Max: 10.05
Current: 9.33
During the past 13 years, the highest Dividend Yield of Jacobson Pharma was 10.05%. The lowest was 0.60%. And the median was 5.33%.
HKSE:02633's Dividend Yield % is ranked better than 98.23% of 508
companies
in the Drug Manufacturers industry
Industry Median: 2
vs HKSE:02633: 9.33
During the past 12 months, Jacobson Pharma's average Dividends Per Share Growth Rate was 50.80% per year.
During the past 3 years, the average Dividends Per Share Growth Rate was 21.20% per year.
During the past 5 years, the average Dividends Per Share Growth Rate was 25.60% per year.
During the past 13 years, the highest 3-Year average Dividends Per Share Growth Rate of Jacobson Pharma was 84.20% per year. The lowest was -15.00% per year. And the median was 14.10% per year.
The growth rate is calculated with least square regression.
For more information regarding to dividend, please check our Dividend Page.
* Please note that "special dividend" is not included in the calculation of dividend per share and related fields.
Over the long term, the return from dividends has been a significant contributor to the total returns produced by equity securities. Studies by Elroy Dimson, Paul Marsh, and Mike Staunton of Princeton University (2002) found that a market-oriented portfolio, which included reinvested dividends, would have generated nearly 85 times the wealth generated by the same portfolio relying solely on capital gains.
Dividends may also qualify a lower tax rate for investors.
In dividends investing, Payout Ratio and Dividend Growth Rate are the two most important variables for consideration. A lower payout ratio may indicate that the company has more room to increase its dividends.
The historical data trend for Jacobson Pharma's Dividend Yield % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Drug Manufacturers - Specialty & Generic subindustry, Jacobson Pharma's Dividend Yield %, along with its competitors' market caps and Dividend Yield % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Jacobson Pharma Dividend Yield % vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Jacobson Pharma's Dividend Yield % distribution charts can be found below:
* The bar in red indicates where Jacobson Pharma's Dividend Yield % falls into.
Dividend Yield measures how much a company pays out in dividends each year relative to its share price.
Jacobson Pharma Recent Full-Year* Dividend History
Amount
Ex-date
Record Date
Pay Date
Type
Frequency
Forex Rate
HKD 0.042500
2025-12-01
2025-12-03
2025-12-18
Cash Dividend
semi-annually
HKD:HKD 1.000000
* GuruFocus has an internal rule that if the most recent dividend payment frequency is at least 4 times a year, then the full year will be calculated according to the frequency of payment or the one-year time frame, whichever is stricter.
* GuruFocus converts dividend currency to local traded share price currency in order to calculate dividend yield. Please refer to the last column "Forex Rate" in the above table.
Jacobson Pharma's Trailing Annual Dividend Yield (%) for Today is calculated as
Trailing Annual Dividend Yield
=
Most Recent Full Year Dividend
/
Current Share Price
=
0.0425
/
1.035
=
4.11 %
Current Share Price is HK$1.035. Jacobson Pharma's Dividends per Share for the trailing twelve months (TTM) ended in Today is HK$0.0425.
Jacobson Pharma's Forward Annual Dividend Yield (%) for Today is calculated as
Forward Annual Dividend Yield
=
Forward Full Year Dividend
/
Current Share Price
=
0.085
/
1.035
=
8.21 %
Current Share Price is HK$1.035. Jacobson Pharma's Dividends per Share for the forward twelve months is calculated as HK$0.0425 * 2 = HK$0.085.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Jacobson Pharma (HKSE:02633) has a Dividend Yield % of 9.33% as of Sep. 02, 2026. Dividend yield is the ratio of company dividends to the share price. View historical data on Jacobson Pharma and its competitors. This is 75% above median its historical median of 5.33. Over the past decade, Jacobson Pharma's Dividend Yield % has ranged from 0.60 to 10.05. According to the industry distribution chart, Jacobson Pharma ranks #9 out of 508 companies in the Drug Manufacturers industry, placing it in the top 1.8%.
Is Jacobson Pharma's Dividend Yield % too high?
Jacobson Pharma's current Dividend Yield % of 9.33% is 75% above median its 10-year median of 5.33. Over the past 10 years, this metric has ranged from a low of 0.60 to a high of 10.05. The Drug Manufacturers industry median Dividend Yield % is 2.00. Jacobson Pharma's value of 9.33% is 366.5% above this industry median. Based on the distribution chart, Jacobson Pharma ranks #9 out of 508 companies in the Drug Manufacturers industry, which is in the top quartile — a strong position relative to peers. Overall, Jacobson Pharma has a GF Score™ of 56/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Jacobson Pharma's Dividend Yield % compare to ZTS?
According to the Drug Manufacturers industry distribution chart, Jacobson Pharma ranks #9 out of 508 companies for Dividend Yield %. This places Jacobson Pharma in the top 2% of its industry — outperforming the majority of peers. The industry median Dividend Yield % is 2.00. Jacobson Pharma's value of 9.33% is 366.5% above this benchmark. Historically, Jacobson Pharma's own Dividend Yield % has ranged from 0.60 to 10.05 over the past decade. While the company's 10-year median is 5.33 vs. the industry median of 2.00, Jacobson Pharma has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Dividend Yield % for a Drug Manufacturers company?
The median Dividend Yield % among Drug Manufacturers companies is 2.00, based on 508 companies in the industry. Companies in the top quartile (top 25%) have a Dividend Yield % significantly above this median, while those in the bottom quartile fall well below. However, Dividend Yield % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Jacobson Pharma's current Dividend Yield % of 9.33% is 366.5% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Dividend Yield % mean?
A high Dividend Yield % can signal that a stock is expensive relative to its fundamentals. Dividend yield is the ratio of company dividends to the share price. View historical data on Jacobson Pharma and its competitors. For the Drug Manufacturers industry, the median Dividend Yield % is 2.00 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Jacobson Pharma's current Dividend Yield % is 9.33%, which is 75% above median its own 10-year median of 5.33. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Jacobson Pharma stock overvalued right now?
Based on GuruFocus' analysis, Jacobson Pharma (HKSE:02633) is currently considered Modestly Overvalued. The stock's GF Value™ is HK$0.85, compared to a current price of HK$1.04 — trading 21.8% above its estimated fair value. The current Dividend Yield % is 9.33%, which is 75% above median its 10-year median of 5.33 and 366.5% above the Drug Manufacturers industry median of 2.00. Jacobson Pharma's overall GF Score™ is 56/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Dividend Yield % calculated?
Dividend Yield % is calculated from a company's financial statements. For Jacobson Pharma (HKSE:02633), the current Dividend Yield % is 9.33% as of Sep. 02, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Jacobson Pharma (HKSE:02633) Overvalued in 2026?
Based on GuruFocus' analysis, Jacobson Pharma stock appears to be overvalued.
The current stock price of HK$1.04 is trading 21.8% above its estimated GF Value™ of HK$0.85.
GuruFocus considers Jacobson Pharma to be Modestly Overvalued.
Key valuation signals for HKSE:02633:
Dividend Yield %: 9.33% (75% above median its 10-year median of 5.33)
GF Value™: HK$0.85 vs. price of HK$1.04 (21.8% above fair value)
Industry Position: 366.5% above the Drug Manufacturers median (#9 of 508)
No single metric tells the full story. See the HKSE:02633 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Jacobson Pharma Corp Ltd is an investment holding company. It is principally engaged in the development, production, marketing, and sale of generic drugs. The company's operating segment includes Generic drugs; Branded healthcare, Wholesale, and retail The generic drugs segment develops, manufactures, and distributes a host of off-patent medicines for various therapeutic use. It generates maximum revenue from the Generic drugs segment. Geographically, it derives a majority of its revenue from Hong Kong and also has a presence in Mainland China, Macau, Singapore, and Other Countries.
56GF Score
Get the complete analysis for HKSE:02633
Dividend Yield % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
HKSE:02633 has been successfully added to your 
